Article Details

AbbVie Completes Acquisition of Syndesi Therapeutics, for Up To USD1 Billion - FinSMEs

Retrieved on: 2022-03-06 05:08:01

Tags for this article:

Click the tags to see associated articles and topics

AbbVie Completes Acquisition of Syndesi Therapeutics, for Up To USD1 Billion - FinSMEs. View article details on hiswai:

Excerpt

AbbVie (NYSE: ABBV) completed the acquisition of Syndesi Therapeutics SA, a Belgium-based clinical stage biotechnology company pioneering the ...

Article found on: www.finsmes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up